Evogene Back Under $1 as Nasdaq Deadline Approaches
Evogene Ltd. shares stayed under $1 on Friday, slipping again in light Nasdaq action. The Israeli computational chemistry firm still needs to get back above that level to meet a Nasdaq listing rule. The stock slipped about 3.5% to $0.69 in recent trading after opening at $0.707. Just over 1,000 shares changed hands, making the price jumpy on thin volume.